We analyzed the influence of the transcription factor DFosB on learned helplessness, an animal model of affective disorder wherein a subset of mice exposed to inescapable stress (IS) develop a deficit in escape behavior. Repeated IS induces DFosB in the ventrolateral periaqueductal gray (vlPAG), and levels of the protein are highly predictive of an individual's subsequent behavorial deficit-with the strongest DFosB induction observed in the most resilient animals. Induction of DFosB by IS predominates in substance P-positive neurons in the vlPAG, and the substance P gene, a direct target for DFosB, is downregulated upon DFosB induction. Local overexpression of DFosB in the vlPAG using viral-mediated gene transfer dramatically reduces depression-like behaviors and inhibits stress-induced release of substance P. These results indicate that IS-induced accumulation of DFosB in the vlPAG desensitizes substance P neurons enriched in this area and opposes behavioral despair by promoting active defense responses.
We analyzed the influence of the transcription factor DFosB on learned helplessness, an animal model of affective disorder wherein a subset of mice exposed to inescapable stress (IS) develop a deficit in escape behavior. Repeated IS induces DFosB in the ventrolateral periaqueductal gray (vlPAG) , and levels of the protein are highly predictive of an individual's subsequent behavorial deficit-with the strongest DFosB induction observed in the most resilient animals. Induction of DFosB by IS predominates in substance P-positive neurons in the vlPAG, and the substance P gene, a direct target for DFosB, is downregulated upon DFosB induction. Local overexpression of DFosB in the vlPAG using viral-mediated gene transfer dramatically reduces depression-like behaviors and inhibits stress-induced release of substance P. These results indicate that IS-induced accumulation of DFosB in the vlPAG desensitizes substance P neurons enriched in this area and opposes behavioral despair by promoting active defense responses.
INTRODUCTION
Members of the Fos family of proteins are induced in the brain upon neuronal activation. By dimerizing with members of the Jun family, Fos proteins participate in the formation of activator protein-1 (AP-1) transcription factor complexes, which bind to DNA at AP-1 sites and modulate the activity of target gene promoters (Morgan and Curran, 1995; Pennypacker, 1998) . AP-1-mediated control of transcription has been established as a critical mechanism through which gene expression, and synaptic strength, can be regulated in an experience-dependent manner (Sanyal et al., 2002) . Genes encoding Fos and Jun family proteins have been termed immediate early genes, owing to their rapid and transient pattern of induction. However, a subclass of stable Fos-related antigens (FRAs) was later identified in the brain (Chen et al., 1995; Hope et al., 1994) . We now know that these chronic FRAs are composed of stabilized isoforms of DFosB (Hiroi et al., 1997 (Hiroi et al., , 1998 , a truncated splice variant of FosB that lacks 101 amino acids from the C-terminal end of the full-length protein (Nakabeppu and Nathans, 1991; Yen et al., 1991) . Contrary to FosB and all other Fos family proteins, DFosB persists in brain for an extended period of time, and accumulates to high levels in neurons after repeated stimulation by the same stimulus (see McClung et al., 2004; Nestler et al., 2001) . These unique biochemical features make DFosB an attractive candidate for mediating longterm neuroadaptations in the brain.
Recently, we have shown that exposure to repeated stress causes DFosB to accumulate in several brain regions implicated in emotional learning . Here, we further examined the role of DFosB in processes of emotional adaptation using models of inescapable stress (IS). Repeated experiences of IS in mice disrupts their ability to later express efficient fight/flight responses. This behavioral plasticity process, referred to as ''learned helplessness,'' is sensitive to antidepressants, and is considered a well validated model of affective disorder in rodents. Neuroanatomical pathways mediating learned helplessness have been partly established, and involve monoaminergic systems (Amat et al., 2005; Besson et al., 1998; Takase et al., 2004 Takase et al., , 2005 . Therefore, we focused our analysis on three major monoaminergic cell groups: the dorsal raphe nucleus (DR), ventral tegmental area (VTA), and locus coeruleus (LC). Based on the results presented here, we propose that stressinduced expression DFosB is part of an adaptive mechanism that promotes resilience to IS by inhibiting selective circuits in the brainstem that mediate the expression of passive defense behaviors.
RESULTS

Heterogeneous Escape Deficits Induced by IS in Mice
Mice with no experience of IS (no-IS group, n = 7) displayed consistently short escape latencies and an absence of escape failures across 15 successive escape trials (average escape latency: 3 ± 0 s, escape failures: 0% ± 0%). In the IS group (n = 28), repeated administration of IS resulted in an overall increase in escape latencies (14 ± 1 s, p < 0.001) and an increased proportion of escape failures (44% ± 6%, p < 0.01). Individual responses were highly heterogeneous within the IS group, especially during the last trials of the test session, as indicated by the striking spread in the average escape latencies for the last five sessions ( Figure 1A , right panel). A median split of the average latency for the last five trials defines two subgroups of animals that display dramatically divergent patterns of responses within the IS group. One subgroup (IS-escape deficit) showed an escape deficit that was sustained across the 15 trials, whereas the other subgroup (IS-no escape deficit) recovered escape latencies identical to those of the no-IS group by the end of the test session ( Figure 1A , left panel; two-way ANOVA, significant trial x subgroup interaction F 28,448 = 2.48, p < 0.001).
IS Induces DFosB Accumulation in Monoaminergic Regions
We found a robust increase in the number of FosB immunoreactive cell nuclei in the DR and LC 24 hr after repeated IS, but no change in the VTA ( Figure 1B and Figure S2 in the Supplemental Data, available with this article online). Since the anti-FosB antibody used here targets an epitope common to both DFosB and full-length FosB, and thus does not allow us to differentiate between the two isoforms, we demonstrated in an additional experiment that FosB immunoreactivity at this time point reflects the accumulation of DFosB and not FosB (see Figure S1 ). Thus, no immunolabeling was observed in the same brain sections when an anti-FosB (C terminus) (Perrotti et al., 2005) antibody was used, which recognizes an epitope present only in the full-length FosB protein. The ability of the anti-FosB (C terminus) antibody to effectively detect fulllength FosB was confirmed by detection of the protein in mice sacrificed 3 hr after an acute exposure to inescapable foot shocks ( Figure S1 ), when expression of the full-length isoform is peaking. Similarly, DFosB accumulation did not coincide with induction of c-Fos, which, like full-length FosB, is a short-lived Fos family member ( Figure S1 ). (C) (Left) DFosB accumulates most intensely in the area corresponding to the rostral portion of the DR in IS-no escape deficit group (ANOVA significant interaction between IS and rostrocaudal level, F 12,104 = 21.33, p < 0.001, ***p < 0.001, **p < 0.01 versus IS-no escape deficit) and correlates negatively with the severity of the behavioral deficit (r = À0.69, p < 0.01, n = 18). Data are expressed as mean ± SEM.
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Stress-Induced DFosB Promotes Active Defense DFosB Levels in the Ventrolateral Periaqueductal Gray Correlate Negatively with the Severity of the Behavioral Deficit The majority of FosB-like immunoreactivity induced in the DR region was observed in the lateral margins of this nucleus and comprised an area corresponding to the ventrolateral periaqueductal gray (vlPAG). Comparison of DFosB levels in this area across the spectrum of escape latencies ( Figure 1A) indicates that mice from the IS-no escape deficit group displayed significantly higher levels of DFosB in the vlPAG compared with the animals from the IS-escape deficit group ( Figure 1C) . A similar pattern was seen for DFosB induction in the LC: DFosB levels in IS-no escape deficit group were significantly greater (26 ± 3 cells/mm 2 ) than those of the IS-escape deficit group (17 ± 3; p < 0.05).
Since the strongest induction of DFosB was observed in the vlPAG, as opposed to the LC ( Figure S1A versus Figure S1B ), we performed a more detailed characterization of the cell populations expressing DFosB in this region. Using tryptophan hydroxylase (TPH) as a marker of serotonin neurons, we found that the highest degree of DFosB accumulation occurs specifically at a rostrocaudal level corresponding to the rostral portion of the DR (between À4.24 mm and À4.48 mm relative to bregma). At this level, the number of cells immunoreactive for DFosB correlates inversely with the severity of the behavioral deficit following IS (r = À0.69, p < 0.01, n = 18), with a lower level of DFosB accumulation being predictive of a stronger escape deficit after IS ( Figure 1C ).
We performed a similar analysis in mice exposed to social defeat, another model of IS. In mice perfused 24 hr after the last defeat episode, we also found an overall increase in the number of DFosB-positive nuclei in the vlPAG (ANOVA main effect, F 2,47 = 3.34, p < 0.05). Interestingly, as we had observed in the learned helplessness paradigm, this effect was significant only in the subgroup of resilient animals ( Figure S3 ).
DFosB Is Induced Primarily in Substance P Neurons in the vlPAG We next investigated the cell type in the vlPAG in which IS induced DFosB. By use of combined immunohistochemistry (for DFosB) and in situ hybridization (for substance P mRNA), we found that a majority (63%) of DFosBpositive cells also express substance P (Figures 2A-2C ). In contrast, much lower levels of colocalization were observed between DFosB and serotonin ($10%, using serotonin transporter [SERT] mRNA as a marker) or GABA ($25%, using glutamic acid decarboxylase as a marker). All DFosB expression was neuronal, since complete colocalization was observed with the neuronal marker NeuN and no colocalization was observed with glial fibrillary acidic protein (GFAP) (not shown). The pattern of DFosB induction in nonserotonergic neurons located at the periphery of the DR is similar to the pattern observed in the LC. In this latter region most DFosBpositive cells were seen just lateral to the boundary of LC noradrenergic neurons, and very few DFosB-positive cells colocalized with expression of the catecholaminergic marker tyrosine hydroxylase ( Figure S1 ).
DFosB Decreases Substance P Gene Expression In Vitro and In Vivo
We tested whether IS-induced DFosB regulates substance P gene expression in three different ways. First we analyzed levels of preprotachykinin A (PPT-A) mRNA, the substance P precursor, over DFosB-positive and DFosB-negative cells by use of a combined immunohistochemistry-in situ hybridization method ( Figure 2B ). The average density of substance P mRNA silver grains was significantly lower over individual DFosB-positive cells compared with DFosB-negative cells (ANOVA effect of cell type, F 2,228 = 27.8, p < 0.001) ( Figure 2D ). This result led us to hypothesize that DFosB accumulation may contribute to repress PPT-A gene transcription. We tested this hypothesis in vitro by a using a promoter assay in PC12 cells in which a luciferase reporter is placed under the control of a 1.3 kb fragment of the PPT-A 5 0 gene promoter. We found that overexpression of DFosB, using a herpes simplex virus (HSV) viral vector, causes a dosedependent repression of the PPT-A promoter compared with use of a control HSV-LacZ vector (ANOVA dose effect, F 2,5 = 5.55, p = 0.053) ( Figure 3A ).
We next sought evidence as to whether this regulation represents a direct effect of DFosB on the PPT-A gene. To test this hypothesis, we performed chromatin immunoprecipitation (ChIP) assays from vlPAG tissue in mice killed 1 or 24 hr after administration of IS (n = 6 per group). We observed a significant enrichment of the PPT-A gene promoter (the region which contains its AP-1 sequences) after immunoprecipitation of chromatin complexes for DFosB (ANOVA main effect of stress, F 1,20 = 4.99 p < 0.05), but not for full-length FosB (ANOVA no effect of stress, F 1,20 = 0.367, nonsignificant) ( Figure 3C ). This effect reached significance only 24 hr after the administration of IS (p < 0.05). This result indicates that DFosB accumulating in substance P-positive neurons in the vlPAG after IS binds directly to the promoter region of the PPT-A gene in vivo.
DFosB in the vlPAG Modulates Stress-Induced Substance P Release in the Nucleus Accumbens To test whether the regulation of substance P gene expression in vlPAG neurons by DFosB may contribute to functional alterations of forebrain substance P neurotransmission, we overexpressed DFosB (or an inactive LacZ construct) locally within the vlPAG using HSV vectors and looked for changes in substance P release in a known projection area of these neurons, the nucleus accumbens (NAc). To mimic the endogenous pattern of expression of DFosB, viral infusions were aimed at the lateral margins of the serotonergic cell population ( Figure 6 ). We measured substance P release, both under baseline conditions and following stress exposure, using in vivo microdialysis in freely moving animals. Baseline extracellular concentrations of substance P in the NAc were not significantly altered by DFosB overexpression (13.9 ± 3.0 fmol/dialysate for the LacZ group and 13.5 ± 1.7 fmol/dialysate for the DFosB group). In contrast, the substance P response to stress and its return to baseline were significantly affected by DFosB: ANOVA effect of time, F 11,165 = 6.74, p < 0.0001; and interaction between virus and time, F 11,165 = 2.07, p = 0.02) ( Figure 3C ). Foot shocks and swim stress each significantly increased substance P efflux in the NAc of LacZ-injected animals by 30% and 120%, respectively. Overexpression of DFosB in the vlPAG significantly attenuated the foot shock-induced and swim stressinduced enhancement of substance P release in this brain region ( Figure 3C ).
NK1 Receptor Blockade in the NAc Has an Antidepressant-like Effect
Our results so far indicated that exposure to IS leads, in resilient animals, to a strong induction of DFosB in the vlPAG, and apparently to a desensitized substance P input to the NAc. To further understand the functional significance of this decreased substance P input, we blocked substance P receptors in the NAc by administering RP67589, a selective NK1 receptor antagonist, prior to the test session. We found that injection of RP67580, either systemically or directly into the NAc, significantly reduced escape latencies (ANOVA main drug effect, F 4,54 = 3.13, p < 0.05) (Figure 4 ). We observed a similar profile of activity in this test after subchronic administration of the traditional antidepressant desipramine (Figure 4 ). Together, these results indicate that decreased substance P signaling in the NAc exerts an antidepressant-like effect and promotes active escape responses in the learned helplessness paradigm.
Overexpression of DFosB in the vlPAG Opposes Behavioral Despair
To further test the hypothesis that DFosB induction in the vlPAG modulates defense responses to IS, we manipulated levels of DFosB or other AP-1-related transcription factors in this brain region using HSV vectors, and we evaluated behavioral responses after exposure to IS. Mice that received intra-vlPAG injections with a control HSV vector expressing LacZ displayed a significant increase in escape latency and an increased proportion of escape failures following IS in the learned helplessness test ( Figures 5A and 5B ), a result in line with our previous observation in noninjected mice (Figure 1 ). These findings indicate that stereotaxic surgery and viral infection per se do not affect IS-induced escape deficits. In contrast, mice injected with HSV-DFosB showed less severe, and nonsignificant, behavioral deficits after IS. This result is consistent with the correlation observed previously and provides direct evidence that induction of this transcription factor in the vlPAG increases resilience to IS. Interestingly, a similar effect was obtained after overexpression of the truncated protein DJunD. In contrast, viral-mediated overexpression of full-length FosB caused the opposite effect and potentiated the severity of the IS-induced escape deficit ( Figures 5A and 5B) . Importantly, none of these viral vectors altered escape behaviors in the absence of IS administration, nor did they have any effects on general locomotion, motor coordination, and sensitivity to foot shocks ( Figures 5C-5E ). Moreover, a similar antidepressant-like effect of HSV-DFosB in the vlPAG was observed in a second, well-validated model that is also sensitive to antidepressant treatments, i.e., the forced swimming test. As illustrated in Figure 6D , DFosB bilaterally injected in the vlPAG reduced floating behavior (p < 0.01) and increased time spent struggling (p < 0.05) and swimming (p < 0.05) compared with control conditions.
DISCUSSION
We have reported recently that exposure to IS causes DFosB to accumulate in several brain regions implicated in the expression of emotional responses . The goal of the present study was to examine the functional consequences of DFosB induction by IS.
Learned Helplessness: Neuroplasticity of Defense Systems Repeated exposure to IS in mice disrupts their ability to later express active fight/flight responses in escapable situations (Chourbaji et al., 2005) . This experience-dependent shift from active defense to a passive behavioral repertoire (i.e., learned helplessness) occurs in some, but not all, animals exposed to IS ( Figure 1A ) and can be corrected by short-term treatment with a broad spectrum of antidepressants ( The selective NK1 receptor antagonist RP67580, administered either systemically or directly into the NAc, significantly reduced escape latencies (ANOVA main drug effect, F 4,54 = 3.13, p < 0.05), an effect shared by the subchronic administration of the antidepressant desipramine in this test. *p < 0.05 and **p < 0.01 from respective control conditions. Intracerebral injection, n = 7 mice per group; systemic drug injection, n = 17-18 group. Data are expressed as mean ± SEM. such as the tricyclic antidepressant desipramine used in the present study (Figure 4 ). In the absence of treatment, extinction of learned helplessness occurs after a short delay in undisturbed animals (Chourbaji et al., 2005; Maier, 2001) . However, exposure to contextual reminders stabilizes escape deficits for several weeks after interruption of the stress (Maier, 2001) , an observation suggesting that IS causes stable neuroplastic changes in neuronal networks mediating defensive responses.
DFosB Accumulates in the DR and LC, but Not in the VTA, after Repeated IS We show here that DFosB accumulates in the DR and LC, but not in the VTA, after repeated administration of IS. A previous study reported an identical pattern of induction of c-Fos upon re-exposure to an environment previously associated with IS (Ishida et al., 2002) . Taken together, these results suggest a preferential involvement of serotonergic and noradrenergic versus dopaminergic cell groups in the associative processes supporting the development of learned helplessness.
DFosB Induction in the DR Area Predicts Individual Degrees of Resilience to IS
It is important to point out that, in our study, increased levels of DFosB were observed in mice perfused 24 hr after the last administration of repeated IS, and immediately after a brief ''escapable'' test session. In these conditions, we presumed that the FosB accumulation is caused by the repeated IS administered 24 and 48 hr beforehand, and not by the brief test session performed 15 min preceding perfusion (which would not allow sufficient time for new protein synthesis). This was confirmed by the observation that mice from the no-IS-yoked group, which received no repeated IS during the training session but the same amount of foot shocks as the IS animals during the test session, showed virtually no DFosB accumulation (Figure 1C) . We also demonstrated that the FosB/DFosB signal 24 hr after IS reflects the accumulation of the stable, truncated isoform DFosB, and not full-length FosB (Figure S1 ). These results are in good agreement with the patterns of expression of DFosB that we have reported earlier in other brain regions in response to stressors IS administration increased the percentage of escape failures (A) and average escape latency (B) in mice that received intra-vlPAG injections of the control HSV-LacZ vector (n = 19), similar to results seen in noninjected animals (see Figure 1) . In contrast, HSV-DFosB (n = 18), as well as HSV-DJunD (n = 11), reduced the development of such escape deficits, while HSV-FosB (n = 12) had the opposite effect. ANOVA main effect of IS on escape latency, F 3,68 = 12.88, p < 0.001, and percentage of escape failures, F 3,68 = 12.36, p < 0.001, *p < 0.05, ***p < 0.001 versus animals from the no-IS condition. None of these viral vectors altered escape performances in the absence of IS administration. Overexpression of DFosB also decreased immobility in the rat forced swimming test (C) (p < 0.01) while increasing time spent struggling (p < 0.05) and swimming (p < 0.05); n = 8-9 per group. On the other hand, HSV-DFosB did not alter sensitivity to foot shocks (D), general locomotion (E), motor coordination (F), or social interactions (not shown). Data are expressed as mean ± SEM. and many other types of stimuli (McClung et al., 2004; Perrotti et al., 2004 Perrotti et al., , 2005 .
In the region where the highest degree of induction is observed (the vlPAG, corresponding to the rostral portion of the DR), the number of cells immunopositive for DFosB was inversely proportional to the severity of the escape deficit after IS ( Figure 1C) . In other words, the level of DFosB induction by IS in this brain region predicts the individual degree of resilience to IS. To test whether this pattern of DFosB expression is produced specifically by the learned helplessness paradigm (or whether it may result from exposure to other types of repeated IS), we evaluated DFosB levels in the vlPAG of mice subjected to another IS paradigm which elicits learned effects that are sensitive to antidepressants. Using a repeated social defeat paradigm, which also triggers long-lasting alterations of defense responses , we observed a similar relationship between the level of DFosB in the vlPAG and the individual degrees of resilience (see Figure S1 ). This observation suggests that DFosB induction may constitute a signature neuroadaptation in defense circuits that is uniquely linked to the development of resilience to IS. The origin of the behavioral and physiological interindividual variations observed here is unknown. Since our experimental population is composed of inbred mice, these variations cannot be attributed to genetic heterogeneity, but may reflect epigenetic, stochastic, or environmental influences .
DFosB Induction Occurs in Passive Coping-Related Circuits in the vlPAG Closer examination of the pattern of induction of DFosB in the DR region indicates that immunopositive cell nuclei are clustered in the lateral margins of the rostral DR, within the vlPAG (Abrams et al., 2004) . This distinctive pattern of induction is particularly interesting since the vlPAG has been characterized previously as an important neural substrate for passive coping responses (Bandler and Shipley, 1994) . IS, which induces primarily passive behavioral responses, engages the vlPAG (Bandler and Shipley, 1994) . Reciprocally, activation of the vlPAG (using electrical stimulation or infusion of excitatory amino acids) evokes passive behavioral coping reactions of quiescence or immobility and hyporeactivity to the environment (Bandler and Shipley, 1994; Johnson et al., 2004) , i.e., a behavioral profile similar to the one observed in helpless mice during the test session. Based on these observations, we hypothesized that IS-induced accumulation of DFosB, and subsequent alterations in AP-1 transcription, may act to desensitize passive coping-related circuits in the vlPAG.
DFosB in the vlPAG Mediates Its Antidepressant-like Effects by Acting as an Endogenous Antagonist of AP-1 Sites
Considerable evidence indicates that DFosB can act as either a transcriptional repressor or activator both in vitro and in vivo (Chen et al., 1997; Dobrazanski et al., 1991; McClung and Nestler, 2003; Nakabeppu and Nathans, 1991; Wisdon and Verma, 1993; Yen et al., 1991) . The similar antidepressant-like activity of both DFosB and DJunD overexpression in the vlPAG ( Figure 5 ) suggests that DFosB acts in this region after IS as an endogenous antagonist of AP-1 transcription. Indeed, DJunD, which lacks an N-terminal transactivation domain, is a truncated variant of JunD, the major in vivo partner for DFosB (Chen et al., 1995; Hiroi et al., 1998) . In Jun family members, truncation of the highly conserved N-terminal transactivation domain always creates dominant-negative antagonists of AP-1-mediated transcription (Brown et al., 1996; Hirai et al., 1989; Lloyd et al., 1991; Peakman et al., 2003; Struhl, 1988 ). This conclusion is also reinforced by the observation of an opposite (prodepressant) behavioral The injections were aimed at the lateral margins of the DR in order to mimic the endogenous pattern of DFosB induction after IS (see Figure 1B and Figure S1 ). (A) Serotonergic neurons were immunolabeled with an antibody against tryptophan hydroxylase, and (B) the viral overexpression was revealed with an antibody against DFosB. The overlays at low (C) and high (D) magnification confirm the location of the infection at the lateral margins of the serotonergic cell groups (D). Dashed triangles indicate the position of the aqueduct on each picture.
influence exerted by full-length FosB, a transcription factor unambiguously characterized as an AP-1 activator (Schuermann et al., 1991; Wisdon and Verma, 1993; Yen et al., 1991) . It will be important in future studies to identify the factors that determine whether DFosB represses or activates a given target gene.
Substance P Is a Direct Target of DFosB in the vlPAG
Given the clustering of DFosB-expressing cells at the periphery of the DR in the vlPAG, we hypothesized that these cells may express the neuropeptide substance P, which is known to be expressed in this area with a similar pattern (Barbaresi, 1998; Harlan et al., 1989; Hurd et al., 1999; Warden and Young, 1988) . Our in situ hybridization results confirmed that the DFosB immunopositive cell population is composed primarily of substance Pexpressing neurons. It is not clear which type of neurons coexpress substance P in this region of the mouse brain. Although substance P has been shown to be highly colocalized with serotonin in the human DR, and to a lesser extent in the rat's, this does not seem to be the case in the mouse, at least at this rostrocaudal level (Chan-Palay et al., 1978) . Colabeling for GAD-67 mRNA suggests that GABAergic neurons represent only a low proportion of the DFosB-expressing population, although we cannot exclude the possibility that some GABAergic neurons in this region may express other isoforms of GAD (Day et al., 2004) .
The PPT-A gene encoding substance P is reported to contain AP-1-like sites within its 5 0 promoter region (Fiskerstrand et al., 2000; Paterson et al., 1995) . Therefore, we tested the possibility that IS induction of DFosB in substance P-positive neurons might feed back and regulate expression of substance P in these cells. Our ChIP data indicate that the PPT-A gene is in fact a direct target of DFosB in these neurons: increased binding of DFosB, but not full-length FosB, occurs at the PPT-A promoter after IS. This binding activity is delayed and reaches significance at 24 hr after the administration of IS. The PPT-A promoter region evaluated for FosB/DFosB binding spans the nucleotides À420 to À256 upstream of the transcription start site. Binding of c-Fos containing AP-1 complexes to this regulatoty region, which contains two tandem AP-1 elements, has been shown to stimulate PPT-A transcription (Paterson et al., 1995) . This is consistent with our interpretation that DFosB, acting as a transcriptional repressor, inhibits PPT-A expression, while full-length FosB activates it.
DFosB Limits the Activation of Substance P Neurotransmission during IS: An Adaptive, Negative-Feedback Mechanism Substance P neurons within the vlPAG are known to send their principal ascending projections to the NAc and the amygdala (Li et al., 1990a (Li et al., , 1990b , a subset of brain regions implicated in defense responses wherein the primary receptor for substance P (NK1) is enriched. As shown in the present study, exposure to experimental stresses triggers the release of substance P in the NAc, whereas blockade of NK1 receptors in this brain region has antidepressant properties, consistent with the substantial literature for a role of substance P and NK1 in depression models (Bilkei-Gorzo et al., 2002; Boyce et al., 2001; Ebner et al., 2004; Rupniak et al., 2000; Smith et al., 1999) . Our in vitro and in vivo results indicate that the accumulation of DFosB in the vlPAG after IS represses substance P gene expression in this brain region and desensitizes stress-induced substance P release in the NAc (Figure 2 and Figure 3) . These data support a model in which repeated activation of substance P neurons in the vlPAG would lead to an AP-1-mediated desensitization of the vlPAG-NAc substance P pathway. This desensitization, the state of which can be mimicked by NK1 antagonists infused into the forebrain (Ebner and Singewald, 2006) , would occur only in a subset of animals, and contribute to the inhibition of passive coping-related circuits and the maintenance of an active behavioral repertoire. In the rest of the population, in which DFosB levels do not accumulate sufficiently to repress substance P signaling, a quiescent behavioral repertoire would gradually develop upon re-exposure to the stressor. In addition to these effects in distal projection areas, a possible regulation of neuronal networks within the PAG itself, by substance P expressed and released locally, might be relevant to the development of learned helplessness (Barbaresi, 1998; Jansen et al., 1998; Johnson et al., 2004) . Indeed, substance P neurons from the vlPAG project to, and possibly regulate the activity of, the nearby serotonin neurons in the DR through a glutamatedependent mechanism (Valentino and Commons, 2005) . Accordingly, the infusion of substance P or NK1 agonists within the DR/vlPAG modulates the firing of serotonin neurons (Valentino and Commons, 2005) and inhibits escape responses induced by IS Mongeau et al., 1998) .
Our present results provide a fundamentally novel and testable model for the mechanisms of resilience. Our future studies will test the hypothesis that antidepressant treatments may enhance resilience by stimulating these same adaptive processes which occur spontaneously in some, but not all, of the individuals in a population exposed to chronic stress.
EXPERIMENTAL PROCEDURES
Animals
Eight-week-old C57 male mice (Jackson Labs, Bar Harbor, ME) were used in all but the microdialysis experiments. Animals were housed four to five per cage in a colony maintained at constant temperature (23 C) with a 12:12 hr light/dark cycle (lights on from 7:00 a.m. to 7:00 p.m.) and ad libitum food and water. All procedures were approved by the Institutional Animal Care and Use Committee of UT Southwestern.
For microdialysis experiments male Sprague-Dawley rats weighing 250-350 g (Charles River, Sulzfeld, Germany) were used. Prior to use, the animals were housed in groups of four to six under controlled laboratory conditions (12:12 hr light/dark cycle with lights on at 7:00 a.m., 21
C ± 1 C, 60% humidity, and ad libitum food and water).
Behavioral Procedures
All behavioral procedures in mice, save for the measures of motor coordination and social interaction, were performed using the active avoidance system of Med Associates (Georgia, VT). This system is a shuttle box divided into two compartments separated by an automated door. A grid floor delivers scrambled shocks to either side of the box. Movements of mice are detected using photocells.
IS, or Training Sessions
On days 1 and 2, mice receiving inescapable shocks (IS group) were confined in one compartment of the shuttle box and received 120 instances of IS through the grid floor (0.45 mA, 5 s duration). IS was distributed randomly over 1 hr, with an average intershock interval of 30 s. Animals from the no-IS and no-IS-yoked groups were placed in the same apparatus for 1 hr, but were not administered any IS. Escape Trials, or Testing Sessions Mice were reintroduced into the shuttle box for 15 consecutive escape trials. During each trial, a continuous shock was delivered and mice were given the opportunity to escape it by entering the adjacent, unelectrified compartment. Following a successful escape, the door was automatically shut and the escape latency recorded. When mice did not escape within 25 s, the trial was terminated and recorded as a failure. An additional no-IS-yoked group was used, in which mice were not given the opportunity to escape shocks during the test session, but were individually coupled to the mice from the IS group, and thus received the exact same amount of shocks. In experiments including pharmacological treatments, mice were pretested on day 3, after vehicle administration, to establish baseline escape latency and balance experimental groups. They were tested again on day 6 after repeated vehicle or drug administration. Locomotor Activity Independent groups of mice were used to determine effects of viral infusions on locomotor activity. On day 4 and 5 after surgery, animals were habituated to the shuttle box for 1 hr, and on day 6 locomotor activity was measured for 15 min. Sensitivity to Foot Shocks Independent groups of mice were used to determine the threshold sensitivity to foot shocks. Mice were placed in the shuttle box and after 2 min of habituation, foot shocks were administered every 30 s, starting at 0.05 mA with a 0.05 mA increment between each shock. The first appearance of a flinch, a jump, and an audible vocalization were recorded.
Rotarod Test of Motor Coordination
For the rotarod test (IITC Life Science, Woodland Hills, CA), each mouse was placed on a rotating rod accelerating from 0 to 45 rpm in 60 s. The speed, the latency to fall, and the distance traveled on the rod were measured. The test was repeated for a total of 8 runs, each 15 min apart. Social Defeat and Avoidance Social defeat and avoidance testing were performed according to previously published protocols Tsankova et al., 2006) . Experimental mice were submitted to 10 consecutive days of social defeat and were evaluated for social approach/avoidance on day 11. Time spent in the interaction zone during the first (no social target) and second (target present) 2.5 min interaction trials was evaluated. ''Truly defeated mice'' were defined as the mice with an interaction ratio <100%, whereas resilient mice had interaction ratios >100% (V.K., M. Han, D. Graham, O.B., W. Renthal, Q. Laplant, A. Graham, S. Russo, M. Lutter, and D. Lagace, unpublished data). For immunohistochemistry, mice were perfused immediately following the termination of the 5 min test session, 24 hr after the last defeat experience.
Stereotaxic Surgery
Mice were anesthetized using ketamine/xylazine solution, and stereotaxic surgery was performed under standard conditions (Hommel et al., 2003) . For bilateral viral infusions in the vPAG area, Hamilton syringe needles (at a 22 angle) were targeted to 0.56 mm caudal to interaural line, +0.80 mm lateral to midline, and 2.80 mm ventral from dura. A total of 0.5 ml of purified HSV virus was delivered on each side over a 4 min period, followed by 6 min of rest. Mice were then left undisturbed for 3 days (Barrot et al., 2002) and started the first training session on day 4 post surgery. For verification of injection sites, brains were processed as described above and slices corresponding to the region of interest were inspected under a microscope. Animals were rejected when injection sites were found on slices outside of the À4.24 mm to À4.72 mm interval respective to bregma, or outside of the 1 mm 2 region described above. Less than 15% of all animals were rejected due to inaccurate injection sites.
To administer drugs into the NAc of awake, freely moving mice, bilateral guide cannulas (26G, 4.5 mm long, 1.5 mm apart, Plastics One, Roanoke, VA) were chronically implanted in this brain region. (+1.2 mm anteroposterior [AP], À4.5 mm dorsoventral [DV] ) and secured with Cerebond (myNeuroLab, St. Louis, MO). Mice were singly housed and left to recover for 10 days post surgery. On the day of the intracerebral infusion, bilateral injectors (33G, projecting 0.5 mm below the tip of the guide, Plastics One, Roanoke, VA) were inserted into the guides for the duration of the infusion.
For microdialysis experiments, rats were anesthetized with sodium pentobarbital/ ketamine. They first received bilateral microinjections of HSV virus (1 ml on each side over a 6 min period, followed by 2 min of rest) into the vlPAG (coordinates: À7.6 mm AP, +0.5 lateral (L), 5.8 mm below the surface of the skull). Immediately after vlPAG infusions, a U-shaped microdialysis probe (1.0 mm membrane, Hemophan, molecular cutoff of 18 kDa) was implanted into each animal's NAc (1.6 mm rostral to bregma, 1.2 mm lateral to the midline, 7.8 mm below the surface of the skull). After surgery, rats were housed individually and left to recover for 3 days, during which they received daily handling. For histological verification of the localization of viral injections and microdialysis probe placement, brains were sectioned and 30 mm coronal sections were stained with cresyl violet.
Microdialysis with Simultaneous Behavioral Analysis
Microdialysis experiments were conducted as described (Ebner et al., 2004) , 3 days after surgery, in rats previously habituated to the procedure room for 24 hr.
Briefly, the probe was connected to a microsyringe pump and superfused with artificial cerebrospinal fluid (see Ebner et al., 2004 for details). Samples were collected every 30 min and stored at À80 C until assay. The first four samples were collected as baseline release for substance P. At the beginning of the fifth dialysis interval, animals were transferred for 20 min into a Plexiglas chamber equipped with a grid floor delivering electric shocks (0.7 mA, ten inescapable shocks, duration of 5 s each, 1 shock every 120 s). After the last shock, rats were returned to their home cages and four consecutive 30 min dialysates were collected. Rats were then transferred from their home cages to a swim tank (35 3 35 3 42 cm; filled with water at 20 C up to a 30 cm height) for 10 min with ongoing dialysis. During the forced swimming procedure, behavior was videotaped and scored a posteriori by a trained observer. The behavior of the animals was assigned to one of the three following behavioral categories: (1) struggling, (2) swimming, and (3) floating. After 10 min the animals were returned to their home cages and microdialysis was continued for 80 min. The concentration of substance P was measured in microdialysates using a highly sensitive radioimmunoassay (detection limit 0.1 fmol/sample). For detailed descriptions see Ebner et al. (2004) .
Drug Treatments
Desipramine (20 mg/kg, Sigma) and RP67580 (5 mg/kg, Tocris) were given subcutaneously in 10 ml/kg of 1% DMSO. The injections were performed once daily for four consecutive days, with the last injection 30 min prior to testing in the learned helplessness paradigm. For intracerebral administration, RP67580 to a concentration of 1 mM was infused in a volume of 1 ml over 5 min, with 0.1% DMSO as a vehicle. The injector was left in place for 2 extra minutes to allow diffusion of the drug, and the mice were immediately tested in the learned helplessness paradigm.
Immunohistochemistry and Combined ImmunohistochemistryIn Situ Hybridization
Immunohistochemistry Perfusion (conducted immediately after the 15 min test session) and staining were performed according to standard procedures (Peakman et al., 2003) . For FosB detection we used a 1:500 dilution of a rabbit polyclonal antiserum (SC7203, SantaCruz Biotechnology, Santa Cruz, CA), and TPH immunolabeling was performed using a 1:1000 dilution of a sheep polyclonal antiserum (AB1541, Chemicon, Temecula, CA). Combined Immunohistochemistry-In Situ Hybridization Sections were prepared and stained with the FosB antibody as described above but with the following modifications (Peakman et al., 2003) . Imunolabeling was conducted in RNase-free conditions and revealed using the avidin-biotin complex method and DAB. Sections were hybridized overnight at 60 C in buffer containing 35 Slabeled RNA probes at 2.0 3 10 6 counts per minute per slide. Autoradiography and emulsion procedures were conducted as described elsewhere (Peakman et al., 2003) . Riboprobes Antisense 35 S-labeled riboprobes were transcribed in the presence of 35 S-UTP and purified by using RNA Quickspin columns (Roche, Basel, Switzerland). PPT-A riboprobe template was a 468 bp fragment corresponding to nucleotides 25-532 of the rat PPT mRNA (Krause et al., 1987) . The template was linearized using HinDIII and transcribed using T7 RNA polymerase. GAD-67 riboprobe was transcribed using T7 RNA polymerase from a 360 bp template (nucleotides 1324-1683 of the feline GAD-67 cDNA, 94% homologous to the murine sequence) linearized with BamHI (Jones et al., 1994) . To produce a ribobrobe against the SERT, a 470 bp fragment of the murine 5-HTT cDNA corresponding to the 3 0 UTR of the short spliced variant (nucleotides 143-613 of exon 14; see Bengel et al., 1997) was subcloned into a TOPO cloning vector (Invitrogen, Carlsbad, CA). For in vitro transcription of antisense probe, the vector was linearized using XhoI and transcribed using SP6 RNA polymerase.
Cell Countings
After double-labeling for FosB and trypyophan hydroxylase, FosBpositive nuclei were counted from coronal views of the DR (1.1 mm 2 area extending 1.1 mm ventral to the tip of the aqueduct and 0.55 mm lateral to the midline). All pictures were captured the same day under fixed microscope and camera settings. Cell counts from captured images were averaged for each animal across three consecutive slides at six independent rostrocaudal levels ranging from À4.24 mm to À4.96 mm relative to bregma. Rostrocaudal levels were determined using the pattern of TPH labeling as a landmark (see Figure S1 ). We also referred to a published anatomic atlas of TPH immunoreactivity (Abrams et al., 2004) .
Silver Grain Countings
Silver grains were quantified after in situ hybridization using a Leeds microscope equipped with an x-y-z stage connected to a personal computer running Bioquant Nova (Bioquant Image Analysis, Nashville, TN). Pictures were captured from random sites inside of the area of interest using a 1003 magnification. All the pictures were captured the same day under fixed microscope and camera settings.
Quantification of Double-Labeling
The relative degree of colocalization of FosB with SERT mRNA, GAD-67, or PPT-A mRNA was evaluated. Cresyl violet (FosB-negative) or DAB (FosB-positive) -stained cells were surrounded by a 20 mm diameter circle. Silver grains inside of each defined circle were digitized and their cumulated area was determined using the Bioquant software. The same procedure was used to measure grain density at random background sites. A cell was considered positive for a given mRNA signal when the density of silver grains was more than three times over the average background density for a given riboprobe. A total of 150 cells from three slides in three animals from the IS condition were counted for each riboprobe. The same approach was used to evaluate the effect of DFosB expression on the levels of PPT-A mRNA. Grain density was expressed as a ratio of grain area to cellular area. A total of 60 FosB-positive and 150 FosB-negative cells were analyzed from three slices in three animals from the IS condition.
ChIP Assays
Punch dissections of vlPAG from mice submitted to the IS or control condition were taken 1 and 24 hr after the end of the second training session. Tissues were crosslinked, washed, and pooled between three to four mice. ChIP was performed based on a protocol from Upstate Biotechnology ChIP kit and published methods (Tsankova et al., 2004) . Aliquots of fixed, sheared chromatin were incubated overnight, first with mouse anti-FosB antibody (C terminus antibody; Center for Biomedical Inventions, UT Southwestern), which recognizes fulllength FosB only, followed by rabbit anti-FosB antibody (SC048 Santa Cruz, CA), which recognizes the middle region of both full-length FosB and DFosB. Nonimmune IgG was used as a control. The binding of full-length FosB and DFosB to the PPT-A promoter was determined by measuring the amount of the PPT-A promoter pulled down in chromatin immunoprecipitates by use of real-time PCR (ABI Prism 7700, Applied Biosystems, Foster City, CA) using the following oligonucleotide pairs. For the PPT-A promoter the primers 5 0 -GCGGAAGTTATTTGGCTGTC-3 0 and 5 0 -ACAATCTGACGCCCTCC TC-3 0 amplified a 164 bp product spanning the portion À420 to À256, a region known to contain an AP-1-AP-1-E Box sequence necessary for transcriptional regulation of PPT-A by AP-1 complexes (Paterson et al., 1995) . The oligonucleotides used for the synaptophysin control promoter were TCATCTGGTAGAACTGAGCGGTC-3 0 and 5 0 -GAGGCTGTGGGTTTTAGAGGAA-3 0 .
Viral Vectors
Construction and packaging of viral vectors has been described previously (Barrot et al., 2002) . Transgenes (cDNAs for Lacz, FosB, DFosB, and DJunD149) were inserted into the HSV amplicon HSVPrPUC and packaged into the virus using the helper 5 dl1.2, as described previously (see Neve et al., 2005) . The average titer of viral stocks was 2.0 3 10 7 infectious units/ml. Clone #63024, obtained from the American Type Culture Collection (ATCC, Rockville, MD) and comprising a 1.67 kb insert encoding mouse JunD, was used to produce DJunD (or DJunD149) by PCR. DJunD is a truncated JunD insert that begins at amino acid 149, immediately after the homologous His that terminates the transactivation domain in all Jun family members. A FLAG epitope tag, a suitable Kozak sequence, and an initiating Met residue were also incorporated into the forward PCR primer. The resulting 617 bp PCR product was gel purified and subcloned into the HSV PrpUC at the EcoR1 site. This DJunD is distinct from the previously described endogenous short variant of JunD, DJunD48, which only lacks 48 amino acids (144 bp) at the N-terminal extension (Okazaki et al., 1998) and displays only subtle functional differences when compared with the full-length JunD protein Pfarr, 2001, 2002) . In contrast, DJunD149 used here has virtually no transactivational activity and, instead, functions as a dominant-negative of AP-1-mediated transcription (Hirai et al., 1989; McClung and Nestler, 2003; Peakman et al., 2003; Struhl, 1988) .
Luciferase Assays
Luciferase assays were performed as described previously (Peakman et al., 2003) using a PPT-A-LUC reporter plasmid (courtesy of J.P. Quinn, University of Edinburgh, UK). A fragment of the PPT-A promoter spanning nucleotides -865 to +447 was subcloned into a pGL3-basic vector (Promega, Madison, WI) expressing firefly luciferase (Fiskerstrand et al., 2000) . PC12 cells were cotransfected with the PPT-A-LUC reporter plasmid and the Renilla luciferase reporter pRL-TK to control for transfection efficiency. After 24 hr, cells were infected with HSV-LacZ or HSV-DFosB and harvested after 48 hr. Aliquots normalized for protein concentrations were assayed for reporter gene activity using the Dual-Luciferase Reporter Assay System from Promega.
Statistics
Dual comparisons were performed using Student's t tests except for microdialysis results which were analyzed using nonparametric Mann-Whitney U-tests. For multiple group comparisons and repeated measures, we conducted one-or two-way ANOVAs followed by Fisher post hoc tests.
Supplemental Data
The Supplemental Data for this article can be found online at http:// www.neuron.org/cgi/content/full/55/2/289/DC1/.
